The Timely Rise of the CDMO
|
|
- Violet Newman
- 6 years ago
- Views:
Transcription
1 OneSource Simplicity and speed. Delivered. The Timely Rise of the CDMO The healthcare sector can improve its margins by tens of billions of dollars and improve patient safety by making supply chain improvements. 1 1 McKinsey report, Building New Strengths in the Healthcare Supply Chain
2 Why revisit your supply chain? The cost of bringing new drugs to market continues to rise. Regulators are demanding more (and more detailed) clinical evidence. Today s complex molecules small and large require an enormous range of technologies that usher in new challenges. Being first to market matters more than ever before. And when you factor in that a growing majority of new molecule development is coming from small and emerging companies, it s clear that a new method of drug production has to emerge. Biopharma companies of all sizes look to vendors to help manage development, manufacturing, and capacity needs. The question is: are they keeping up? For a very specific set of development partners, the answer is yes. A new breed of solution-centric CDMOs has emerged, with capabilities spanning the entire development and manufacturing process from pre-clinical drug development to commercial-scale manufacturing. While the outsourcing relationship has traditionally been driven by specialty, price or proximity, today s more evolved CDMOs can inject a new value into the equation: strategy. Expertise across the development process gives the savvy CDMO the ability to approach the entire drug-development path holistically to lower costs, shorten timelines, simplify project management and inject needed expertise in areas that biopharmaceutical companies have divested from intentionally. Clearly the rise of the CDMO couldn t have come at a better time. 2
3 Filling a gap While the phrase Best Practices implies the best for an industry, it isn t always the case. Best can differ by company size, scope of project and intended result. After all, the small or emerging company looking to sell their discovery after reaching Proof of Concept probably has a very different set of criteria than a Big Pharma company looking to bring a compound to market. A company that can be put out of business by a low bioavailability score needs to take much more care with their approach than one that can weather setbacks on the way to finally releasing a therapy to market. Where companies of all sizes can agree, however, is that outsourcing to the right partner can provide efficiencies and access to expertise not otherwise available. Perhaps then, there is at least one Best Practice for drug development and commercialization: a strategic CDMO relationship. Virtual & small pharma Small pharma companies have typically found themselves challenged by manufacturing, with its high asset intensity and minimum efficient scale. 2 For the smaller company, it stands to reason they may not have the expertise in-house to move past discovery and on to development. So for them, outsourcing that portion of the process simply makes sense. What also makes sense is to outsource manufacturing capacity, as building it requires huge infrastructure and capital investments that are impractical for a company of this size. Midscale to large pharma As costs have spiraled, more and more larger players have felt the need to trim staff. While that was once restricted to support functions, recent years have seen a growing number of experienced scientists looking for work. Increasingly, they find new roles with CDMOs, which are growing rapidly in size and scope, and hungry to add more talent and capabilities to their roster. Upon joining the CDMO, these scientists find they are exposed to a greater number of projects with more technical variety and many wind up broadening their expertise. As a result, large pharmaceutical companies are, in essence, turning to CDMOs to find the experts they ve lost but who now have even greater skills than before. Any pharma The rise of the CDMO has shifted investment and forecasting risk away from pharmaceutical companies and towards CDMOs. However, it might be more accurate to say that it s a reduction of risk, rather than simply a shift. Given the size, scope and global relationships of CDMOs, they can disperse the forecasting and capacity risk they take on by spreading it across a large number of clients and facilities worldwide. At this scale, the ebb and flow of regular business tends to normalize the peaks and valleys thereby protecting the CDMOs just as they protect their clients. 2 Strategy + Business Is Pharma Ready for the Future? 3
4 A shift from tactical to strategic By virtue of having reached a critical mass of expertise, and holding a fundamentally different point of view about how they can add value, CDMOs are in the position to supply a vertically integrated service with measurable benefits to biopharma: Speed as a product of quality By being responsible for the entire development process, an integrated CDMO can address drug substance and drug product steps at the same time, eliminating typical tech transfer and scale-up issues. Additionally, they can proactively address solubility or manufacturability challenges early in development to avoid costly and timeconsuming rework in late development. While any company can talk about speed, and maybe even impact it for a discrete step or two, only a CDMO with extensive end-to-end experience can deliver speed as a product of quality. Simplified management Working with a single, integrated partner reduces time and complexity in multiple ways: simplified sourcing, fewer contracts, elimination of repetitious project kickoffs, and streamlined process management due to the removal of hand-offs between vendors. Problem resolution is also enhanced with a single point of contact for the entire process, regardless of step. Increased return Given that 80% of prescriptions are for generics, 3 being first to market matters more now than ever before. But merely being first isn t enough. The more time that passes between IND/CTA submission and regulatory approval, the less time there is to capture the market and recoup the investment. Twenty years may sound like plenty of protection, 4 but the average effective patent life is only 11-1/2 years, given the amount of time it takes to navigate clinical trials. 5 Anything that can be done to speed the development process will increase the commercial profile of a drug. Likewise, a CDMO with a large footprint and global capabilities can also reduce risk for clients with second-source options, which gives the ability to flex production up or down to meet actual market demands without requiring costly capital investments or reducing ROI on the drug due to the pervasive practice of over-building to protect against revenue loss from under-capacity. Better problem-solving As the industry continues to create more complex molecules to address more complex conditions, it requires new technologies and processes that add their own levels of complication to the process. This, too, speaks to the value of CDMOs. When a CDMO reaches a size where they are involved in the majority of development programs, they gain firsthand knowledge that can be applied to other projects. Size also leads to end-to-end capabilities, which can promote a holistic view of development. This creates opportunities to proactively solve challenges the CDMO knows will come up before they actually do. Manufacturing process as a strategic advantage While many large pharmaceutical companies view owning manufacturing as vital to their success, it s yet another opportunity for a CDMO to add value. Tier 1 CDMOs bring more products to market in any given year than even the largest pharmaceutical company. That level of experience pays dividends across the entire process, including manufacturing especially when the product or ingredients are unstable, cytotoxic or require other special handling. 3 FDA (fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/understandinggenericdrugs/ucm htm) 4 FDA (fda.gov/drugs/developmentapproval Process/ucm htm) 5 4
5 How do you know if you could benefit by partnering with a CDMO? The indicators are clearer than you might think: If you re concerned about growing beyond your current funding, a CDMO gives you access to the expertise you need at much lower cost than hiring. This is especially useful for companies angling for a quick sale of their molecule after achieving Proof of Concept. a CDMO lets you transfer the risk of building new capacity to meet uncertain market demand to them. As stated above, a CDMO can shift excess capacity between projects or clients much more readily than a pharmaceutical company can. If you fear you ve lost your agility, a CDMO can help you gain speed efficiencies that may be difficult to find internally without significant process changes. If you need to control capital expenditures, Evaluating a new class of partners According to a Nice Insight survey, quality and reliability topped the priority list for sponsors looking to outsource development for the third year in a row. 6 As more companies start to refer to themselves as CDMOs, however, it raises the question of how to evaluate them properly. A few key offerings across development and commercialization certainly aren t enough. Nor is a cobbled-together process that seems to cover the entire spectrum but lacks the free flow of information and expertise across disciplines. The true CDMO offers superior, integrated, end-to-end quality across the entire drug-development continuum and backs it with measurable results. It is our view that quality is the single attribute that can never be sacrificed. It must be central to the entire process for an integrated offering to have any value. To help discover whether the quality and reliability are there, look at the following criteria when evaluating a CDMO: 1. Proof of expertise through the number of approved NMEs and NDAs 2. Proven ability to fast-track through parallel-process activities 3. Global reach and access to full range of capabilities 4. Range of technologies to address today s niche and specialty products (e.g., cytotoxic, high-potency) 5. Ability to eliminate redundant activities 6. Proven skill in tech transfer 7. Solubility and bioavailability expertise 8. Solution focus versus capacity utilization focus 9. Ability to optimize use of precious API 10. End-to-end project management and partnership approach 11. Routine regulatory inspections with minimal defects These criteria are important because the number of companies that meet them is certainly much smaller than the number of companies that refer to themselves as CDMOs. And unlike in investing, past performance is absolutely an indicator of future success in drug development and commercialization. 6 Life Science Leader - Outsourcing Increasing To CROs And CMOs Known For Quality And Cost-Effectiveness 5
6 Setting the standard for CDMOs Understanding why this new breed of CDMO exists, and how to evaluate them, leads very naturally to the topic of which CDMO is the best. Talk to a pharmaceutical company that has worked with Patheon and you ll hear about our deep expertise across Drug Substance, Formulation Development and Drug Product services. You ll also hear about, our unwavering commitment to quality, and our ability to add value to any development process. Patheon excels at every individual step, which makes us the natural company to pioneer the complete integrated offering. We have no weak links, so you experience no disappointments. And that is the singular strength of our singular offering. The market created the need. Patheon OneSource is the answer. Patheon OneSource offers: A single, integrated end-to-end offering A single point of contact and accountability who manages every step of your development journey About Patheon Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 8,400 employees worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered. Continuous collaboration of DS & DP teams to deliver informed decisions throughout your entire product lifecycle Elimination of incomplete information transfer Unified quality system for DS & DP Single harmonized Quality Agreement Savings of 8-20 weeks, depending on molecule type Patheon 4815 Emperor Blvd, Suite 300 Durham NC USA P: F: To learn more about Patheon OneSource, visit or call Patheon Kingfisher Drive Covingham, Swindon Wiltshire SN3 5BZ UK P: F: Patheon 7F Wakamatsu Building, Nihonbashi Hon-cho, Chuo-ku, Tokyo Japan P: F: doingbusiness@patheon.com
How can pharma outsourcing partners overcome the challenges of a rapidly changing industry?
How can pharma outsourcing partners overcome the challenges of a rapidly changing industry? ADAPTING TO CHANGE IN CONTRACT PHARMA How can pharma outsourcing partners overcome the challenges of a rapidly
More informationMcKinsey Center for Government What's Driving the Recent Surge in New Drug Approvals?
McKinsey Center for Government What's Driving the Recent Surge in New Drug Approvals? Alexia Cesar, Philip Ma, Navjot Singh, Jeff Smith What's Driving the Recent Surge in New Drug Approvals? In 2012, the
More informationEmerging Trends in Regulatory Outsourcing WHITE PAPER.
WHITE PAPER www.makrocare.com/consulting You are not alone in the quest for bringing your products to market and improve the quality of the life for millions! MakroCare brings you the insight on how a
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More informationApplying Lean Principles to Your Business Processes 6 Simple Steps to More Business Insight, Control and Efficiency
Applying Lean Principles to Your Business Processes 6 Simple Steps to More Business Insight, Control and Efficiency 2016 TrackVia, Inc. All rights reserved. CONTENTS Introduction Why most business processes
More informationESTIMATE THE IMPACT OF TIME SAVINGS ON YOUR DRUG DEVELOPMENT PROGRAM, ASSET VALUE AND FINANCIAL COMPANY PERFORMANCE
ESTIMATE THE IMPACT OF TIME SAVINGS ON YOUR DRUG DEVELOPMENT PROGRAM, ASSET VALUE AND FINANCIAL COMPANY PERFORMANCE An Economic Comparison of Programmatic and Transactional Development Models PETER SAUSEN,
More informationDevOps Guide: How to Use APM to Enhance Performance Testing
DevOps Guide: How to Use APM to Enhance Performance Testing CHAPTER 1: Introduction This short ebook discusses how combining performance test automation with application performance management (APM) solutions
More informationAccenture and Salesforce. Delivering enterprise cloud solutions that help accelerate business value and enable high performance
Accenture and Salesforce Delivering enterprise cloud solutions that help accelerate business value and enable high performance 1 Businesses and governments around the world are increasingly adopting and
More informationBIOPHARMA SOLUTIONS TM Expedite Your Drug Development Program
BIOPHARMA SOLUTIONS TM Expedite Your Drug Program Maximize the Value of Your Asset The journey of drug development can be complex stressful. But it doesn t have to be that way. Join more than 600 biopharmaceutical
More informationKseniia Jones Senior Manager Global Risk Advisory Deloitte UK
Inside magazine - Edition 2018 You and I were The rise of managed services Hugo Morris Partner Managed Risk Services Deloitte UK Mark Whitehead Director UK Risk Advisory Deloitte UK Kseniia Jones Senior
More informationGE Digital Executive Brief. Enhance your ability to produce the right goods in time to satisfy customer demand
Enhance your ability to produce the right goods in time to satisfy customer demand Traditionally, successful production has relied heavily on skilled personnel. Experienced employees installed equipment
More informationDigital Insight CGI IT UK Ltd. Digital Customer Experience. Digital Employee Experience
Digital Insight Digital Customer Experience Digital Employee Experience Digital Insight Internet of Things Payments IP Solutions Cyber Security Cloud 2015 CGI IT UK Ltd. Contents Introduction Business
More informationOptimization: The Next Frontier
Optimization: The Next Frontier A White Paper Impact Advisors LLC January 2015 400 E. Diehl Road Suite 190 Naperville IL 60563 1 800 680 7570 Impact Advisors.com Table of Contents Introduction... 3 Optimization
More informationTalent Acquisition Leader s Guide to Recruitment Agency Planning. Setting Your Agency Recruiting Strategy for 2017
Talent Acquisition Leader s Guide to Recruitment Agency Planning Setting Your Agency Recruiting Strategy for 2017 Introduction Recruiting agencies are a big business. In fact, Staffing Industry Analysts
More informationGlobal Contract Research Organization (CRO) Market: Size, Trends & Forecasts ( ) November 2017
Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts (2017-2021) November 2017 Global Contract Research Organization (CRO) Market : Coverage Executive Summary and Scope Introduction/Market
More informationPlaying catch up or leapfrog?
Are you agile, efficient and flexible? Playing catch up or leapfrog? Instead of playing catch up, chemical process companies could leap ahead of competitors. Are you agile, efficient and flexible? 2 Change
More informationbest practices in promotion planning and execution Work Smarter and Improve Performance
best practices in promotion planning and execution Work Smarter and Improve Performance table of contents Where Are Retail Promotions Headed? 2 better tools can help 4 Impact across retail departments
More informationHelping unlock growth opportunities worldwide
Helping unlock growth opportunities worldwide A trusted partner for high-stakes decisions While scientific and technological advances fuel new business opportunities, the cost of bringing each new product
More informationComplex Generics: Charting a new path
White paper Complex Generics: Charting a new path Complex generics offer a lucrative market for drug manufacturers, but only if they can adapt to a more complicated and challenging development process.
More informationBio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies
Global Strategy Global Challenges Executable Solutions Bio-Pharma: China 2010-2020 A Look at The FUTURE: 4 th & 5 th Generation Global Strategies France Houdard Managing Director January 2010 Table of
More informationA High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges
A High-Touch Approach to Improving Patient Access Using field support to navigate reimbursement challenges For the brand and reimbursement teams who must develop commercial strategies for the biopharmaceutical
More informationWHITE PAPER. Big Pharma, Big Data - Big Deal? Yes, Really! Abstract. - Sunil S. Desai and Bill Peer
WHITE PAPER Big Pharma, Big Data - Big Deal? Yes, Really! - Sunil S. Desai and Bill Peer Abstract Companies in the Pharmaceutical industry are being increasingly inundated with data that most are simply
More informationBioPharm. Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships
BioPharm Volume 25 Number 3 INTERNATIONAL March 2012 The Science & Business of Biopharmaceuticals Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships Outsourcing decisions should
More informationCapabilities Overview Presentation. Presenter
Capabilities Overview Presentation Presenter About Baxter Global, diversified healthcare company 80 years of parenteral expertise driven by a well recognized global brand $12.6 billion global market leader
More informationManagement in Pharmaceutical Industry
Master Program Management: Industrial Management Module: Chemistry for Drug Substances Management in Pharmaceutical Industry Prof. Tatsiana Savitskaya Assoc. Prof. Iryna Kimlenka Lectures 5,6 The Key Aspects:
More informationLife Sciences Practice
Life Sciences Practice The healthcare landscape has recently experienced considerable changes, including highly visible public demands for safer and improved healthcare systems. At the core of this is
More informationMaximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS
Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8
More informationUNIFYING THE CUSTOMER JOURNEY 4 WAYS CALLBACK IN THE CLOUD IMPROVES THE CUSTOMER EXPERIENCE
UNIFYING THE CUSTOMER JOURNEY 4 WAYS CALLBACK IN THE CLOUD IMPROVES THE CUSTOMER EXPERIENCE TABLE OF CONTENTS Introduction Page 3 Integrated business groups ensure a consistent experience Page 4 Elimination
More informationContinuous Quality Assurance
White Paper Silk Central Connect Continuous Quality Assurance Deliver Great Software the Business Needs Table of Contents page Executive Summary...2 63% of All Software Projects Don t Succeed...2 40% of
More informationDATWYLER SEALING SOLUTIONS HEALTH CARE
DATWYLER SEALING SOLUTIONS HEALTH CARE Datwyler Sealing Solutions is a Swiss-based, leading supplier and a key player in the global health care industry. With more than 100 years of experience, we have
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7
More informationA full-service CRO with integrated early-stage capabilities
CHARLES RIVER TO ACQUIRE ARGENTA and BIOFOCUS A full-service CRO with integrated early-stage capabilities James C. Foster Chairman, President & CEO Thomas F. Ackerman Executive Vice President & CFO March
More informationADP Vantage HCM Transforming the way business gets done
SOLUTIONS OVERVIEW ADP Vantage HCM Transforming the way business gets done HR. Payroll. Benefits. HCM Turning hurdles into opportunities Global growth. An increasingly mobile and multigenerational workforce.
More informationHow can regulatory affairs drive greater value for the patient and for the business?
How can regulatory affairs drive greater value for the patient and for the business? Exploring the key considerations How do you combat the rising costs of regulatory affairs? What s the best operating
More informationMyth Busted: Affordable, Easy to manage Virtualization with High-Availability is a Reality
Myth Busted: Affordable, Easy to manage Virtualization with High-Availability is a Reality EXECUTIVE SUMMARY By Dan Kusnetzky, Distinguished Analyst Business organizations are looking to virtualization
More informationINTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES
WHITE PAPER INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES Randomization is fundamental to clinical trials it enables treatment group balance, eliminates selection bias and limits
More informationCHATBOTS & INTELLIGENT VIRTUAL ASSISTANTS
CHATBOTS & INTELLIGENT VIRTUAL ASSISTANTS FOR PHARMA AN FAQ-STYLE GUIDE Info@ 509-242-0767 Artificial intelligence (AI) is transforming businesses across industries and continents, allowing those who invest
More informationPAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust
PAREXEL PARTNER PROGRAM Broaden your reach with a partner you can trust YOUR JOURNEY. OUR MISSION. Combining technology and services to provide the right solution to help you and your clients succeed REGARDLESS
More informationACCENTURE TECHNOLOGY VISION FOR ORACLE 2017 TREND 2 ECOSYSTEM POWER PLAYS
ACCENTURE TECHNOLOGY VISION FOR ORACLE 2017 TREND 2 ECOSYSTEM POWER PLAYS INTRODUCTION Accenture and Oracle s work together, showcased in this Accenture Technology Vision for Oracle 2017, demonstrates
More informationONESOURCE VIRTUAL DEDICATED EXCLUSIVELY TO WORKDAY. Application Management Services Payroll Services
ONESOURCE VIRTUAL DEDICATED EXCLUSIVELY TO WORKDAY Application Management Services Payroll Services Global Consulting Deployment Finance and Accounting Outsourcing 1 DEDICATED TO AND DELIVERED 100 % WITHIN
More informationAchieve Your Business and IT Goals with Help from CA Services
Achieve Your Business and IT Goals with Help from CA Services How Does CA Services Approach an Engagement? Whether its planning, implementing or running our industry leading software, CA Services can help
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More informationChallenges of Analytical Method Transfer in the Pharmaceutical Industry
Challenges of Analytical Method Transfer in the Pharmaceutical Industry White Paper Author: Steve Alley, Technical Specialist 1 Contents Introduction 2 Method Transfer Team 3 Identify Methods 4 Gap Analysis
More informationKey Definitions 6/16/2015
Technology Transfer from a CDMO Perspective Joe Cobb, CPIP Director, Pharmaceutical Development Metrics Contract Services, a division of Mayne Pharma US 18-June-2015 Key Definitions CDMO Contract Development/Manufacturing
More informationHealth Solutions. Commercial Health Solutions Overview EXPANDING INSIGHT. ENSURING VALUE. IMPROVING OUTCOMES.
Health Solutions Commercial Health Solutions Overview EXPANDING INSIGHT. ENSURING VALUE. IMPROVING OUTCOMES. Expanding Insight. Ensuring Value. Improving Outcomes. Organizations look to experienced solutions
More informationAnalytical Methods Development and Validation
Understanding and Implementing Efficient Analytical Methods Development and Validation Jay Breaux, Kevin Jones, and Pierre Boulas Analytical methods development and validation play important roles in the
More informationThe Risk Management + Design Controls Connection: What Device Makers Need to Know
!!! The Risk Management + Design Controls Connection: What Device Makers Need to Know Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Intended Use & User Needs 6 Verification, Validation,
More informationOperationalizing NPS Benchmarks. How to Use Comparative Data to Drive Customer Experience Success
Operationalizing NPS Benchmarks How to Use Comparative Data to Drive Customer Experience Success Overview Net Promoter Score (NPS ) has become the most widely accepted measure of customer loyalty and retention.
More informationService Desk Metrics
AN INTRO TO Service Desk Metrics An introductory guide to Service Desk Metrics including definitions, importance & key correlations. MetricNet, LLC - IT Service and Support Benchmarking - 1 TABLE OF CONTENTS
More informationYASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.
YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA wns wns ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN
More informationGlobal Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research
Transparency Market Research Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Buy Now Request Sample Published Date: April 2014 Single User License: US
More informationAccelerate Your Digital Transformation
SAP Value Assurance Accelerate Your Digital Transformation Quick-Start Transformation with SAP Value Assurance Service Packages 1 / 17 Table of Contents 2017 SAP SE or an SAP affiliate company. All rights
More informationFour Factors to Consider When Building Complex Production Systems
Four Factors to Consider When Building Complex Production Systems When machine builders partner with subsystem specialists to simplify and streamline their equipment design, engineering, production, and
More informationRecruiting Leader s Guide to Direct Hire Agency Planning
Recruiting Leader s Guide to Direct Hire Agency Planning Setting Your Agency Recruiting Strategy for 2016 Recruiting Leader s Guide to Direct Hire Agency Planning 2 INTRODUCTION Direct hire agencies are
More informationQuintiles Transnational Corporation Big is Beautiful
Company Overview Quintiles Transnational Corporation Big is Beautiful Quintiles Transnational is the market leader in providing a full range of integrated product development and commercial development
More informationThe Coaching Playbook. Your Must-Have Game Plan for Maximizing Employee Performance
The Coaching Playbook Your Must-Have Game Plan for Maximizing Employee Performance CONTENTS Coaching Overview What is Coaching? Coaching Categories Coaching Relationships Who Can Be a Coach? Coaching Personas
More informationJune HCM Webinar: HR Shared Services Benchmarking Results, Trends, and Key Metrics. Karen Hilton, ScottMadden Scott Manning, ScottMadden
June HCM Webinar: HR Shared Services Benchmarking Results, Trends, and Key Metrics Karen Hilton, ScottMadden Scott Manning, ScottMadden Presenters Karen Hilton Partner Scott Manning Partner and Corporate
More information2016 CRO LEADERSHIP AWARDS. Page Life Science Leader s readership of pharmaceutical and biopharmaceutical executives have told us about
List Of Winners Page 28-34 Company Profiles Page 35-42 Life Science Leader s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in efficiently vetting potential
More informationExperience the commitment. CGI Exploration2Revenue TM Business Suite. Optimize your upstream back office
Experience the commitment CGI Exploration2Revenue TM Business Suite Optimize your upstream back office Delivering a competitive edge Today s oil and gas companies are challenged to lower the costs of running
More informationTracking and Measuring Physician Relations
Tracking and Measuring Physician Relations experience. insight. impact. Using Technology For Greater Success By Allison McCarthy, MBA Tracking and measuring the success of physician relations program has
More informationBUSINESS AGILITY IS humanly possible
BUSINESS AGILITY is humanly possible We ve entered the Human Age, when the old rules of business are giving way to the new. In today s complex business environment, technology and capital no longer guarantee
More informationRetail: Tips for Reducing Recruitment Costs
White Paper Retail: Tips for Reducing Recruitment Costs Increase Your Hiring Performance while Decreasing Cost-to-Fill Recruiting in retail presents some pretty big challenges compared to other industries.
More informationAmgen Supply Chain Segmentation The Journey to October 23, 2014
Amgen Supply Chain Segmentation The Journey to 2022 October 23, 2014 Introduction Rayne Waller VP Global Supply Chain at Amgen Responsible for: Corporate and Regional Supply Chain Functions Contract Manufacturing
More informationGIANCARLO POLI SAMUEL CORRAL PHILIP KYTE
GIANCARLO POLI SAMUEL CORRAL PHILIP KYTE LEADING CORPORATE QUALITY DEPARTMENTS ARE SHEDDING THEIR BIG BROTHER REPUTATION. Known for years as the group that delivered the final yea or nay on products, Quality
More informationINTELLIGENT VIRTUAL ASSISTANTS
INTELLIGENT VIRTUAL ASSISTANTS FOR PAYERS AN FAQ-STYLE GET STARTED GUIDE Info@ 509-242-0767 Artificial intelligence (AI) is transforming businesses across industries and continents, allowing those who
More informationA Proven Path for Improving Government Debt Collection
ISSUE PAPER Experience the commitment A Proven Path for Improving Government Debt Collection This issue paper describes a proven path to maximizing revenue collection using modern tools and techniques,
More informationStrengthen Every Link in Your Digital Supply Chain
Strengthen Every Link in Your Digital Supply Chain Axway solutions for end-to-end visibility and ecosystem engagement reinforce enterprise innovation and growth. BROCHURE In the age of immediacy, make
More informationWhy Web-Enable Your Legacy Application?
Why Web-Enable Your Legacy Application? Over the years, you have invested massive resources into developing, maintaining and operating your company's aging legacy application. That ongoing need for scarce
More informationIn-Process Automation
www.hcltech.com In-Process Automation business assurance & testing Author: Sajitha Radhakrishnan SL CORE APPS-TESTING-TESTING-FT-BFSI HCL Technologies Ltd., Bangalore, India Sajitha.R@hcl.com WHITEPAPER
More informationINFORMATION STREAMLINES
INFORMATION STREAMLINES Cut Costs, Innovate, and Reduce Risk Agile Product Lifecycle Management for Process Gain Visibility into the Entire Product Lifecycle Thrive despite challenging economic conditions
More information< < CLOSING THE COMPETITIVE OPPORTUNITY GAP DEVELOP YOUR STRATEGY OUR WORLDWIDE PRESENCE OPTIMIZE YOUR SYSTEMS SIMPLIFY YOUR ENVIRONMENT
CLOSING < < PAYMENTS INDUSTRY BY THE NUMBERS These statistics are indicative of a definitive shift that s taking place in the payments market: 1/3 of retail banking revenues will go to new non-bank players
More informationOracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite
Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite April 12, 2012 Oracle is currently reviewing
More informationAssessing the Economics of Single-Source vs. Multi-Vendor Manufacturing
Assessing the Economics of Single-Source vs. Multi-Vendor Manufacturing Tufts Center for the Study of Drug Development, Tufts University School of Medicine Boston, MA October 2017 Joseph A. DiMasi, Ph.D.,
More informationBest Practices in Promotion Planning and Execution
Best Practices in Promotion Planning and Execution Work Smarter and Improve Performance Next Best Practices in Promotion Planning and Execution Work Smarter and Improve Performance Table of Contents Where
More informationSTATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY
STATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY State of the Asia-Pacific Pharmaceutical Industry The pharmaceutical industry in the Asia-Pacific region has recently been besieged
More informationSmart Outsourcing: Strategic Alignment, Risk Management, and New Relationships
Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships Outsourcing decisions should be made to foster potential long-term strategic partnerships. Mar 02, 2012 By Ian Uydess, William
More informationEvolving Growth Strategies for Offshore BPO Suppliers
2008 EVOLVING GROWTH STRATEGIES FOR OFFSHORE BPO SUPPLIERS Evolving Growth Strategies for Offshore BPO Suppliers What are the key questions and critical elements of strategic decision-making in developing
More informationPut your customer at the center
Put your customer at the center Intelligence, Automation, and Agility for Digital Transformation October 2017 Don Schuerman, CTO and VP, Product Marketing Digital Transformation is hard I believe the auto
More informationThe Accenture/ Siemens PLM Software Alliance
The Accenture/ Siemens PLM Software Alliance Enabling Efficient Product Lifecycle Management Companies in a wide range of industries rely upon Product Lifecycle Management (PLM) to grow their business,
More informationGxP Auditing, Remediation, and Quality System Resourcing
GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing
More informationQuality Agreements and Managing Contract Supplier Quality
Quality Agreements and Managing Contract Supplier Quality American Society for Quality Lloyd Bailey November 3, 2005 Service Mark of The Dow Chemical Company TM Trademark of The Dow Chemical Company Abstract
More informationMaking Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials
Cognizant 20-20 Insights Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials The industry s Shared Investigator Platform significantly reduces the time and cost
More informationFour entry strategies for small and midsized companies
White paper >7,100 sales reps >220 product launches in 20 countries supported since 2009 Emerging markets: Four entry strategies for small and midsized companies Executive summary Emerging markets offer
More informationCloud Sales Strategy How to Master Cloud Sales in a New Era of Digital Transformation
Cloud Sales Strategy How to Master Cloud Sales in a New Era of Digital Transformation The Cloud opens a world of opportunities to help you scale quickly, enter new markets, and fill your pipeline. But
More informationAppropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products
Date: April 23, 2012 Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Key Messages Importation quality control testing for pharmaceutical, biological/biotechnology
More informationMARKETS & CUSTOMERS. Progressing globalization. Evolving markets
Peptides are used worldwide in medical research. They contribute immensely to the understanding of diseases and have proven to be effective in medicinal products. Today, peptides can be produced at low
More informationAPIXIO HCC PROFILER Reimagining Risk Adjustment
APIXIO HCC PROFILER Reimagining Risk Adjustment Traditional Risk Adjustment Methods Aren t Enough Traditionally, risk adjustment has used manual, low-tech methods of identifying, obtaining, and individually
More informationCRO Outlook 2015: A Paperless Path to a Competitive Advantage
CRO Outlook 2015: A Paperless Path to a Competitive Advantage Dec 22, 2014 By Jennifer Goldsmith Applied Clinical Trials All signs indicate that 2015 should be another good year for contract research organizations
More informationThe Benefits of Using an Appliance to Simplify and Accelerate Desktop Virtualization Initiatives
Brought to you by The Benefits of Using an Appliance to Simplify and Accelerate Desktop Virtualization Initiatives Desktop has become an important technology that helps organizations support an increasingly
More informationElevating the Customer Experience in the Mobile World
Elevating the Customer Experience in the Mobile World Mobile Devices Are an Ever-Present Feature of Our Daily Lives Tablets, phones, watches we rely on them and the applications and services that they
More information"Saltigo - Customized Competence"
News Release Saltigo GmbH Contact: Udo Erbstößer LANXESS Deutschland GmbH Corporate Communications Trade & Technical Press 51369 Leverkusen Germany Phone +49 214 30-54529 Fax +49 214 30-44865 udo.erbstoesser@lanxess.com
More informationIntroduction. Charting the future of customer care through a core optimization philosophy.
Ralf Hiemisch /Getty Images Charting the future of customer care through a core optimization philosophy. Until recently, the majority of the discussions Five dynamics shifting the industry around customer
More informationA drug development crossroad lies ahead
G L O B A L C B O C O S T E F F E C T I V E B I O A N A L Y T I C A L H I G H Q U A L I T Y E A R L Y S T A G E C L I N I C A L T R A N S L A T I O N A L M E D I C I N E H I G H L Y C O M P E T E N T A
More informationThe Science Behind Smart Outsourcing: Four Steps to Success
Analytical Services The Science Behind Smart Outsourcing: Four Steps to Success A Celsis Analytical Services White Paper Table of Contents Introduction 1 The Role and Benefits of Outsourcing 1 Top Considerations
More informationSynoptek Managed AWS: Cloud Optimization & Risk Mitigation
Synoptek Managed AWS: Cloud Optimization & Risk Mitigation Snap your fingers. If you re among those who think that cloud computing works like that, you ve been watching too many commercials. Like the many
More informationCollaborative Development Financing
Collaborative Development Financing 14 by Warren Nachlis and Wendy Brasunas The Growth of the Biotechnology Industry Pharmaceutical drug development is a risky and very expensive process. According to
More informationDevices, Big Data, and Real World Evidence O R A C L E W H I T E P A P E R O C T O B E R
Devices, Big Data, and Real World Evidence O R A C L E W H I T E P A P E R O C T O B E R 2 0 1 7 Disclaimer The following is intended to outline our general product direction. It is intended for information
More information